ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Medical Technology

October 10, 2021
Scholarly endeavour to digest, in a relatively short and dense manuscript, the State-of-the-Art in assessing the function of the Forgotten Chamber. The notion of surgjcal pericardiotomy as a confounder of decision making is most interesting
May 21, 2021
A large RCT concluding that 'surgical occlusion of the left atrial appendage provides additional protection against stroke when added to anticoagulation.' A number of limitations are briefly discussed. Findings are interesting in that absolute absence of surgical complications has been declared.
January 30, 2021
A Canadian multi-centre RCT of immediate baloon-cryoablation of the pulmonary veins: the intervention was compared to the relevant standard of pharmacological care. The target population was treatment-naive sufferers of de novo paroxysmal atrial fibrillation.
November 9, 2020
In a press release early this morning, Pfizer and BioNTech accounced the results of their vaccine candidate against SARS-CoV-2 in the first interim efficacy analysis of its Phase 3 clinical study.
February 20, 2020
This randomized trial evaluated depth and duration of intraoperative hypotension during noncardiac surgery, comparing a machine learning early warning system to standard care. Hypotension was defined as a MAP <65 mm Hg for one minute or more.
October 30, 2019
A balanced  appraisal of last year's manuscript from the Lancet Group on a relatively novel portable Organ Care System for donor lungs. The analysis of the technical complications, especially organ damage from overenthusiastic revving of the pump, is particularly sobering.
July 11, 2019
An important update on the evolving landscape of surgery for atrial fibrillation.
June 27, 2019
An interesting small British-led randomized controlled trial on modern imaging of coronary atheroma.
May 29, 2019
Using period hypercapnea as a surrogate "contrast" agent, myocardial oxygenation was assessed using cardiac MR and accurately mapped areas of relative ischemia.
May 3, 2019
The US FDA approved the Xvivo device for maintaining or resuscitating donor lungs prior to transplant. Interesting very high survival is reported in the control group at one year.

Pages